Evidence map›Paper›PMID 27390452›Full record

ReviewJournal of physical therapy science2016

Mesenchymal stem cells in regenerative rehabilitation.

Jasmin Nurkovic, Zana Dolicanin, Fahrudin Mustafic, Rifat Mujanovic, Mensur Memic, Vesna Grbovic, Aleksandra Jurisic Skevin, Selmina Nurkovic

Open access · diamondAbstract readReview
In one paragraph

Review in Journal of physical therapy science, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 13 papers.

0numbers the graph read from it
0cells of the map it votes in
13citing papers in PubMed
1.6field-weighted citation impact, top 17% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

13 citing papers in PubMed, 23 citations in OpenAlex.

  1. Article
  2. Review
  3. Review
  4. Review
  5. Review
  6. Article
  7. Review
  8. Article
  9. Article
  10. Cell therapy for lung disease.European respiratory review : an official journal of the European Respiratory Society · 2017
    Review
  11. Article
  12. Article
  13. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 4 institutions in 1 country.

Jasmin NurkovicDepartment of Biomedical Sciences, State University of Novi Pazar, Serbia; Center for Physical Medicine and Rehabilitation, Clinical Center Kragujevac, Serbia; Center for Molecular Medicine and Stem Cell Research, Faculty of Medical Sciences, University of Kragujevac, Serbia.
Zana DolicaninDepartment of Biomedical Sciences, State University of Novi Pazar, Serbia; General Hospital Novi Pazar, Serbia.
Fahrudin MustaficDental Center Jezero, Serbia.
Rifat MujanovicDepartment of Biomedical Sciences, State University of Novi Pazar, Serbia.
Mensur MemicDepartment of Biomedical Sciences, State University of Novi Pazar, Serbia.
Vesna GrbovicCenter for Physical Medicine and Rehabilitation, Clinical Center Kragujevac, Serbia; Faculty of Medical Sciences, University of Kragujevac, Serbia.
Aleksandra Jurisic SkevinCenter for Physical Medicine and Rehabilitation, Clinical Center Kragujevac, Serbia; Faculty of Medical Sciences, University of Kragujevac, Serbia.
Selmina NurkovicFaculty of Medical Sciences, University of Kragujevac, Serbia; General Hospital Novi Pazar, Serbia.
University of Kragujevac · RSState University of Novi Pazar · RSClinical Centre of Kragujevac · RSUniverzitet u Novom Pazaru · RS

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

[Purpose] Regenerative medicine and rehabilitation contribute in many ways to a specific plan of care based on a patient's medical status. The intrinsic self-renewing, multipotent, regenerative, and immunosuppressive properties of mesenchymal stem cells offer great promise in the treatment of numerous autoimmune, degenerative, and graft-versus-host diseases, as well as tissue injuries. As such, mesenchymal stem cells represent a therapeutic fortune in regenerative medicine. The aim of this review is to discuss possibilities, limitations, and future clinical applications of mesenchymal stem cells. [Subjects and Methods] The authors have identified and discussed clinically and scientifically relevant articles from PubMed that have met the inclusion criteria. [Results] Direct treatment of muscle injuries, stroke, damaged peripheral nerves, and cartilage with mesenchymal stem cells has been demonstrated to be effective, with synergies seen between cellular and physical therapies. Over the past few years, several researchers, including us, have shown that there are certain limitations in the use of mesenchymal stem cells. Aging and spontaneous malignant transformation of mesenchymal stem cells significantly affect the functionality of these cells. [Conclusion] Definitive conclusions cannot be made by these studies because limited numbers of patients were included. Studies clarifying these results are expected in the near future.

Indexed as

Mesenchymal stem cellsRegenerative rehabilitation

Identifiers

PMID27390452
PMCPMC4932093
OpenAlexW2468603755

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.